Antiatherosclerotic effects of licorice extract supplementation on hypercholesterolemic patients: Increased resistance of LDL to atherogenic modifications, reduced plasma lipid levels, and decreased systolic blood pressure

被引:82
作者
Fuhrman, B
Volkova, N
Kaplan, M
Presser, D
Attias, J
Hayek, T
Aviram, M [1 ]
机构
[1] Rambam Med Ctr, Lipid Res Lab, Haifa, Israel
[2] Technion Israel Inst Technol, Rappaport Family Inst Res Med Sci, Lipid Res Lab, Fac Med, IL-31096 Haifa, Israel
关键词
licorice; flavonoids; lipid peroxidation; low-density lipoprotein; blood pressure; atherosclerosis; hypercholesterolemia;
D O I
10.1016/S0899-9007(01)00753-5
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
OBJECTIVE: We previously demonstrated the beneficial effects of dietary flavonoids derived from the ethanolic extract of licorice root against atherosclerotic lesion development in association with inhibition of low-density lipoprotein (LDL) oxidation in atherosclerotic mice. Administration of licorice extract to normolipidemic subjects also inhibited LDL oxidation. In the present study, we extended our investigation to analyze the antiatherogenic effects of Licorice-root extract consumption in moderately hypercholesterolemic patients. METHODS: Supplementation of licorice root extract (0.1 g/d) to patients for 1 mo was followed by an additional I mo of placebo consumption. RESULTS: Licorice consumption 1) reduced patients' plasma susceptibility to oxidation (by 19%); 2) increased resistance of plasma LDL against three major atherogenic modifications: oxidation (by 55%), aggregation (by 28%), and retention, estimated as chondroitin sulfate binding ability (by 25%); 3) reduced plasma cholesterol levels (by 5%), which was due to a 9% reduction in plasma LDL cholesterol levels; and 4) reduced (by 14%) plasma triacylglycerol levels. After the 1 mo of placebo consumption, these parameters reversed toward baseline levels. Licorice extract supplementation also reduced systolic blood pressure by 10%, which was sustained during the placebo consumption. CONCLUSIONS: Dietary consumption of licorice-root extract by hypercholesterolemic patients may act as a moderate hypocholesterolemic nutrient and a potent antioxidant agent and, hence against cardiovascular disease. (C) Elsevier Science Inc. 2002.
引用
收藏
页码:268 / 273
页数:6
相关论文
共 36 条
[1]   DIETARY OLIVE OIL REDUCES LOW-DENSITY-LIPOPROTEIN UPTAKE BY MACROPHAGES AND DECREASES THE SUSCEPTIBILITY OF THE LIPOPROTEIN TO UNDERGO LIPID-PEROXIDATION [J].
AVIRAM, M ;
EIAS, K .
ANNALS OF NUTRITION AND METABOLISM, 1993, 37 (02) :75-84
[2]   PLASMA-LIPOPROTEIN SEPARATION BY DISCONTINUOUS DENSITY GRADIENT ULTRA-CENTRIFUGATION IN HYPERLIPOPROTEINEMIC PATIENTS [J].
AVIRAM, M .
BIOCHEMICAL MEDICINE, 1983, 30 (01) :111-118
[3]   LESIONED LOW-DENSITY-LIPOPROTEIN IN ATHEROSCLEROTIC APOLIPOPROTEIN E-DEFICIENT TRANSGENIC MICE AND IN HUMANS IS OXIDIZED AND AGGREGATED [J].
AVIRAM, M ;
MAOR, I ;
KEIDAR, S ;
HAYEK, T ;
OIKNINE, J ;
BAREL, Y ;
ADLER, Z ;
KERTZMAN, V ;
MILO, S .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 216 (02) :501-513
[4]  
Aviram M, 1996, EUR J CLIN CHEM CLIN, V34, P599
[5]   Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants [J].
Aviram, M ;
Rosenblat, M ;
Billecke, S ;
Erogul, J ;
Sorenson, R ;
Bisgaier, CL ;
Newton, RS ;
La Du, B .
FREE RADICAL BIOLOGY AND MEDICINE, 1999, 26 (7-8) :892-904
[6]   Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions - A possible peroxidative role for paraoxonase [J].
Aviram, M ;
Rosenblat, M ;
Bisgaier, CL ;
Newton, RS ;
Primo-Parmo, SL ;
La Du, BN .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (08) :1581-1590
[7]   Pomegranate juice consumption inhibits serum angiotensin converting enzyme activity and reduces systolic blood pressure [J].
Aviram, M ;
Dornfeld, L .
ATHEROSCLEROSIS, 2001, 158 (01) :195-198
[8]   Polyphenolic flavonoids inhibit macrophage-mediated oxidation of LDL and attenuate atherogenesis [J].
Aviram, M ;
Fuhrman, B .
ATHEROSCLEROSIS, 1998, 137 :S45-S50
[9]  
Aviram M, 2000, FREE RADICAL RES, V33, pS85
[10]  
Aviram M, 2000, AM J CLIN NUTR, V71, P1062